310 related articles for article (PubMed ID: 24070987)
21. Disease and pharmacologic risk factors for first and subsequent episodes of equine laminitis: A cohort study of free-text electronic medical records.
Welsh CE; Duz M; Parkin TDH; Marshall JF
Prev Vet Med; 2017 Jan; 136():11-18. PubMed ID: 28010903
[TBL] [Abstract][Full Text] [Related]
22. Aggregate risk study of exposure to endophyte-infected (Acremonium coenophialum) tall fescue as a risk factor for laminitis in horses.
Rohrbach BW; Green EM; Oliver JW; Schneider JF
Am J Vet Res; 1995 Jan; 56(1):22-6. PubMed ID: 7695144
[TBL] [Abstract][Full Text] [Related]
23. A multicenter, matched case-control study of risk factors for equine laminitis.
Alford P; Geller S; Richrdson B; Slater M; Honnas C; Foreman J; Robinson J; Messer M; Roberts M; Goble D; Hood D; Chaffin M
Prev Vet Med; 2001 May; 49(3-4):209-22. PubMed ID: 11311954
[TBL] [Abstract][Full Text] [Related]
24. The pharmacologic basis for the treatment of endocrinopathic laminitis.
Durham A
Vet Clin North Am Equine Pract; 2010 Aug; 26(2):303-14. PubMed ID: 20699177
[TBL] [Abstract][Full Text] [Related]
25. Risk factors for equine laminitis: a systematic review with quality appraisal of published evidence.
Wylie CE; Collins SN; Verheyen KL; Newton JR
Vet J; 2012 Jul; 193(1):58-66. PubMed ID: 22104504
[TBL] [Abstract][Full Text] [Related]
26. The application of a new laminitis scoring method to model the rate and pattern of improvement from equine endocrinopathic laminitis in a clinical setting.
Meier A; McGree J; Klee R; Preuß J; Reiche D; de Laat M; Sillence M
BMC Vet Res; 2021 Jan; 17(1):16. PubMed ID: 33413384
[TBL] [Abstract][Full Text] [Related]
27. Pasture-associated laminitis.
Geor RJ
Vet Clin North Am Equine Pract; 2009 Apr; 25(1):39-50, v-vi. PubMed ID: 19303549
[TBL] [Abstract][Full Text] [Related]
28. Case-control study of risk factors for pasture-and endocrinopathy-associated laminitis in North American horses.
Coleman MC; Belknap JK; Eades SC; Galantino-Homer HL; Hunt RJ; Geor RJ; McCue ME; McIlwraith CW; Moore RM; Peroni JF; Townsend HG; White NA; Cummings KJ; Ivanek-Miojevic R; Cohen ND
J Am Vet Med Assoc; 2018 Aug; 253(4):470-478. PubMed ID: 30058970
[TBL] [Abstract][Full Text] [Related]
29. Severity and outcome of equine pasture-associated laminitis managed in first opinion practice in the UK.
Menzies-Gow NJ; Stevens K; Barr A; Camm I; Pfeiffer D; Marr CM
Vet Rec; 2010 Sep; 167(10):364-9. PubMed ID: 20817896
[TBL] [Abstract][Full Text] [Related]
30. Approaches to endocrinopathic laminitis in the field: Results of a survey of veterinary practitioners in North America.
Rumfola E; Banse HE; Atkins M; McGowan CM; Ireland JL
J Equine Vet Sci; 2022 Mar; 110():103856. PubMed ID: 34958881
[TBL] [Abstract][Full Text] [Related]
31. Pathology of Natural Cases of Equine Endocrinopathic Laminitis Associated With Hyperinsulinemia.
Karikoski NP; McGowan CM; Singer ER; Asplin KE; Tulamo RM; Patterson-Kane JC
Vet Pathol; 2015 Sep; 52(5):945-56. PubMed ID: 25232034
[TBL] [Abstract][Full Text] [Related]
32. Prophylactic digital cryotherapy is associated with decreased incidence of laminitis in horses diagnosed with colitis.
Kullmann A; Holcombe SJ; Hurcombe SD; Roessner HA; Hauptman JG; Geor RJ; Belknap J
Equine Vet J; 2014 Sep; 46(5):554-9. PubMed ID: 23927380
[TBL] [Abstract][Full Text] [Related]
33. [The effect of a treatment protocol on the prognosis of equine laminitis].
Oosterlaan-Mayer B; Back W; Sloet van Oldruitenborgh-Oosterbaan MM
Tijdschr Diergeneeskd; 2002 Nov; 127(21):644-9. PubMed ID: 12449656
[TBL] [Abstract][Full Text] [Related]
34. Prevalence and factors associated with development of laminitis in horses with duodenitis/proximal jejunitis: 33 cases (1985-1991).
Cohen ND; Parson EM; Seahorn TL; Carter GK
J Am Vet Med Assoc; 1994 Jan; 204(2):250-4. PubMed ID: 8144386
[TBL] [Abstract][Full Text] [Related]
35. Prospective cohort study evaluating risk factors for the development of pasture-associated laminitis in the United Kingdom.
Menzies-Gow NJ; Harris PA; Elliott J
Equine Vet J; 2017 May; 49(3):300-306. PubMed ID: 27363591
[TBL] [Abstract][Full Text] [Related]
36. In vitro and in vivo studies of homocysteine in equine tissues: implications for the pathophysiology of laminitis.
Berhane Y; Bailey SR; Harris PA; Griffiths MJ; Elliott J
Equine Vet J; 2004 Apr; 36(3):279-84. PubMed ID: 15147138
[TBL] [Abstract][Full Text] [Related]
37. Age, breed, sex and seasonality as risk factors for equine laminitis.
Polzer J; Slater MR
Prev Vet Med; 1997 Jan; 29(3):179-84. PubMed ID: 9234403
[TBL] [Abstract][Full Text] [Related]
38. Endocrinopathic laminitis.
McGowan CM
Vet Clin North Am Equine Pract; 2010 Aug; 26(2):233-7. PubMed ID: 20699171
[TBL] [Abstract][Full Text] [Related]
39. Preventive health care and owner-reported disease prevalence of horses and ponies in Great Britain.
Ireland JL; Wylie CE; Collins SN; Verheyen KL; Newton JR
Res Vet Sci; 2013 Oct; 95(2):418-24. PubMed ID: 23768693
[TBL] [Abstract][Full Text] [Related]
40. Descriptive epidemiological study of equine laminitis.
Slater MR; Hood DM; Carter GK
Equine Vet J; 1995 Sep; 27(5):364-7. PubMed ID: 8654351
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
